Keywords: Obstructive sleep apnea, OSA, Continuous positive airway pressure, CPAP, oral appliance, daytime sleepiness, snoring, sleep related breathing disorder, and apnea hypopnea index.
A person with a sleep related breathing disorder might be the last person to know he or she has a problem. Usually complaining of the most common symptoms, daytime sleepiness and loud snoring, patients with Obstructive sleep apnea (OSA) are often unaware of their disorder. OSA is the most common sleep related breathing disorder and can be treated with the use of a Continuous Positive Airway pressure (CPAP) which remains the most common method of treatment for patients with moderate to severe OSA. If a patient is unable to tolerate the CPAP, an oral appliance may be used to treat their mild to moderate OSA. At AZTMJ, Dr. Stan Farrell has extensive training in treating sleep apnea and other sleep disorders. Dr. Stan Farrell offers one of the leading alternatives for the CPAP, which is an oral appliance that can be used in conjunction with a CPAP or as a stand-alone oral appliance depending on the severity of the individual’s OSA. If you or someone you know might be suffering from obstructive sleep apnea, please schedule an initial consultation today with Dr. Farrell at 480-945-3629 or visit us at www.az-tmj.com for more information.
Kabir A1, Ifteqar S, Bhat A. 1Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Missouri at Kansas City School of Medicine, Kansas City, MO.
Abstract: Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder characterized by repeated episodes of obstructed (apnea) or reduced (hypopnea) airflow in the upper airway during sleep. Obstructive sleep apnea results in variable arterial oxygen desaturations and arousals leading to sleep fragmentation. Most patients with OSA first come to the attention of a clinician when they complain of daytime sleepiness or when their bed partner reports loud snoring and witnessed episodes. Obstructive sleep apnea is associated with impaired quality of life, cardiovascular disease, metabolic syndrome, and motor vehicle accidents, yet the disorder remains undiagnosed in a significant portion of the population. Overnight polysomnography, whether facility-based or portable, is required for appropriate patient diagnosis. Portable monitoring can be used in patients with a high pre-test probability for moderate-to-severe OSA, who are without significant comorbidities. Management of OSA requires a long-term multidisciplinary approach. Continuous positive airway pressure (CPAP) remains the mainstay of treatment for patients with moderate-to-severe OSA. Oral appliances may be indicated in patients with mild-to-moderate OSA who do not wish to use CPAP. Surgical therapy is generally reserved for selected patients in whom CPAP or oral appliance are not an option.